Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAEST16001 in NSCLC
NCT03029273Phase 1Unknown
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial of TAEST16001 in non-small cell lung cancer (NSCLC), sponsored by Guangzhou Institute of Respiratory Health. Status: unknown.
02
Drugs
TAEST16001
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03029273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029273.